{"url_path":"/sec/celg-ri/8-k/2026-05-08/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/14272/0001140361-26-020036-index.html","accession_number":"0001140361-26-020036","cik":"0000014272","ticker":"CELG-RI","issuer_name":"BRISTOL MYERS SQUIBB CO","edgar_url":"https://www.sec.gov/Archives/edgar/data/14272/0001140361-26-020036-index.html","primary_entity_key":"0000014272","primary_entity_name":"BRISTOL MYERS SQUIBB CO"},"word_count":359,"has_tables":true,"body_markdown":"false000001427200000142722026-05-052026-05-050000014272bmy:CelgeneContingentValueRightsMember2026-05-052026-05-050000014272bmy:Three363NotesDue2033Member2026-05-052026-05-050000014272bmy:Two973NotesDue2030Member2026-05-052026-05-050000014272bmy:Three857NotesDue2038Member2026-05-052026-05-050000014272us-gaap:CommonStockMember2026-05-052026-05-050000014272bmy:One750NotesDue2035Member2026-05-052026-05-050000014272bmy:Four581NotesDue2055Member2026-05-052026-05-050000014272bmy:Four289NotesDue2045Member2026-05-052026-05-05\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n \n\nFORM 8-K\n\nCURRENT REPORT\n\n \n\nPursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934\n\n \n\nDate of Report (Date of earliest event reported): May 5, 2026\n\nBRISTOL-MYERS SQUIBB COMPANY\n\n(Exact Name of Registrant as Specified in its Charter)\n\nDelaware\n\n001-01136\n\n22-0790350\n\n(State or Other Jurisdiction of Incorporation)\n\n(Commission File Number)\n\n(IRS Employer Identification Number)\n\nRoute 206 & Province Line Road,\nPrinceton,\n\nNew Jersey 08543\n\n(Address of Principal Executive Office)\n\nRegistrant’s telephone number, including area code: (609)\n252-4621\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of\nthe following provisions (see General Instruction A.2. below):\n\n \n\n☐\n\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n☐\n\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n☐\n\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n☐\n\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\n Securities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol(s)\n\nName of each exchange on which registered\n\nCommon Stock, $0.10 Par Value\n\nBMY\n\nNew York Stock Exchange\n\nCelgene Contingent Value Rights\n\nCELG RT\n\nNew York Stock Exchange\n\n2.973% Notes due 2030\n\nBMY/30\n\nNew York Stock Exchange\n\n3.363% Notes due 2033\n\nBMY/33\n\nNew York Stock Exchange\n\n1.750% Notes due 2035\n\nBMY35\n\nNew York Stock Exchange\n\n3.857% Notes due 2038\n\nBMY/38\n\nNew York Stock Exchange\n\n4.289% Notes due 2045\n\nBMY/45\n\nNew York Stock Exchange\n\n4.581% Notes due 2055\n\nBMY/55\n\nNew York Stock Exchange\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule\n12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised\nfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}